Vigilant Biosciences CEO Matthew H.J. Kim is shown with scientific founder Dr. Elizabeth Franzmann, who is looking at a OncAlert point-of-care test prototype for an early detection system for risk of oral cancer.
Vigilant Biosciences CEO Matthew H.J. Kim is shown with scientific founder Dr. Elizabeth Franzmann, who is looking at a OncAlert point-of-care test prototype for an early detection system for risk of oral cancer. PATRICK FARRELL Miami Herald File Photo
Vigilant Biosciences CEO Matthew H.J. Kim is shown with scientific founder Dr. Elizabeth Franzmann, who is looking at a OncAlert point-of-care test prototype for an early detection system for risk of oral cancer. PATRICK FARRELL Miami Herald File Photo

Vigilant Biosciences cleared to launch its oral cancer test across Europe

May 04, 2016 09:45 AM

More Videos

  • FCC votes to repeal net neutrality regulations

    The Federal Communications Commission voted along party lines to undo 2015 Obama-era “net neutrality” rules that guaranteed equal access to internet on Thursday.